Division of Prismic Pharmaceuticals Inc.
Latest From Scarista Ltd.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
CEOs from Sanofi and GlaxoSmithKline hold forth on how previous years’ preparations have led up to this moment, a post-patent-cliff future for big pharma.
- Therapeutic Areas
- Metabolic Disorders > Diabetes
- Neurology, Nervous System
- Western Europe
- Parent & Subsidiaries
- Prismic Pharmaceuticals Inc.
- Senior Management
- Contact Info
26 Victoria St., Douglas
Isle of Man,
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.